Metacrine Inc. (NASDAQ:MTCR) traded at $0.55 at last check on Monday, January 10, made a downward move of -7.02% on its previous day’s price.
Looking at the stock we see that its previous close was $0.59 with the day’s price range being $0.5689 – $0.62. In terms of its 52-week price range, MTCR has a high of $11.00 and a low of $0.57. The company’s stock has lost about -56.93% over that past 30 days.
3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Metacrine Inc. has a market cap of $16.20 million and is expected to release its quarterly earnings report on Mar 16, 2022 – Mar 21, 2022. Estimates by analysts give the company expected earnings per share (EPS) of -$0.63, with the EPS growth for the year raised at -$2.41 for 2021 and -$1.38 for next year. These figures represent 39.30% and 42.70% growth in EPS for the two years respectively.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the MTCR stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Based on estimates by 4 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 3 have rated the Metacrine Inc. (MTCR) stock as a Hold, while 1 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Hold and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is -41.29% off its SMA20 and -52.53% from its 50-day simple moving average. The RSI (14) is pointing at 28.46 while the volatility over the past week is 9.45% and jumps to 16.17% over the past one month.
Coming back to Metacrine Inc. (NASDAQ:MTCR), we note that the average 3-month trading volume was 3.60 million. Current shares outstanding are 26.52 million.
The insiders hold 20.75% of the company’s shares while institutions hold 47.80%. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -12.47% down in year-to-date price movement.